Derm: alopecia, cutaneous vasculitis, exacerbation of post-radiation erythema, erythema, pruritus, rash.
GU: ↓fertility (males).
Hemat: leukopenia, anemia, hemolytic anemia, macrocytosis, thrombocytopenia.
Metab: hyperuricemia.
Resp: INTERSTITIAL LUNG DISEASE.
Misc: chills, fever, malaise, (INCLUDING LEUKEMIA AND SKIN CANCER)SECONDARY MALIGNANCY .
Head and Neck Cancer or Resistant Chronic Myelogenous Leukemia
- PO (Adults): 15 mg/kg/day as a single dose.
Renal Impairment
- PO (Adults): CCr <60 mL/min or on receiving hemodialysis 7.5 mg/kg/day as a single dose; if on hemodialysis, give dose after dialysis.
Sickle Cell Anemia
- PO (Adults): Droxia 15 mg/kg once daily; may ↑ by 5 mg/kg/day every 12 wk up to 35 mg/kg/day. Siklos 15 mg/kg once daily; may ↑ by 5 mg/kg/day every 8 wk up to 35 mg/kg/day.
- PO (Children 2 yr): Siklos 20 mg/kg once daily (based on ideal or actual body weight, whichever is less); may ↑ by 5 mg/kg/day every 8 wk (or if a painful crisis occurs) up to 35 mg/kg/day.
Renal Impairment
- PO (Adults): CCr <60 mL/min or on receiving hemodialysis Droxia or Siklos: 7.5 mg/kg once daily; if on hemodialysis, give dose after dialysis.
Renal Impairment
- PO (Children 2 yr): CCr <60 mL/min or on receiving hemodialysis Siklos: 10 mg/kg once daily; if on hemodialysis, give dose after dialysis.
Therapeutic Classification: antineoplastics
Pharmacologic Classification: antimetabolites
Absorption: Well absorbed following oral administration.
Distribution: Crosses the blood-brain barrier; concentrates in RBCs and leukocytes.
Metabolism/Excretion: 50% excreted unchanged by the kidneys; 50% metabolized by the liver and eliminated as respiratory CO.
Half-life: 34 hr.
(effects on blood counts)